WASHINGTON — On Tuesday, June 16, Renold “Ren” Capocasale, CEO of Doylestown, PA-based FlowMetric, will take the stage at the Pennsylvania Pavilion to unveil the company’s latest innovation at the BIO International Convention in Philadelphia. This new platform can support flow cytometry based analysis performed literally anywhere in the world, for use in applications such as infectious disease diagnosis, the identification of biological agents and monitoring vaccine efficacy. Its public health, philanthropic and military applications hold great promise.
FlowMetric, an industry leader in flow cytometry-based contract research organization services, launched its global health subsidiary, FlowMetric Diagnostics, in 2014. CEO Ren Capocasale has dedicated his life’s work to advancing unmet medical needs using flow cytometry. The company’s first-to-market technology will be on display at the BIO International 2015 Convention and Mr. Capocasale will be available for interviews.
WHAT: Unveiling of FlowMetric’s Newest Innovation
WHEN: Tuesday, June 16, 2015
Exhibit Hall opens, 9:30 a.m. EST
Product Unveiling, 11:15 a.m. EST
WHO: Renold Capocasale, Founder and CEO, FlowMetric
WHERE: Booth 4227A, Pennsylvania Pavilion
BIO International Convention
Pennsylvania Convention Center
1101 Arch Street
Philadelphia, PA 19107
Help employers find you! Check out all the jobs and post your resume.
